External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum haemorrhage.
D P Riley, R W Burgess
https://pubmed.ncbi.nlm.nih.gov/7818062/Actively Recruiting
Led by LLC UkrMedGroup · Updated on 2025-10-07
20
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the use of the Abdominal Aortic and Junctional Tourniquet - Stabilized AAJT-S device as a temporary treatment for severe postpartum hemorrhage PPH caused by uterine atony that does not respond to standard therapies like uterotonics and balloon tamponade. This multicenter, prospective study focuses on women experiencing heavy bleeding after childbirth in settings where surgical care and blood products may be delayed, such as conflict-affected regions in Ukraine. Participants will receive standard care for PPH initially. If bleeding continues uncontrolled, the AAJT-S device will be applied to the upper abdomen and inflated to 250 mmHg to temporarily block blood flow through the abdominal aorta and inferior vena cava. This device will be used for up to 60 minutes to reduce bleeding and provide time to prepare for surgery and blood transfusion. During the study, women will be closely monitored from device application until six weeks postpartum. Researchers will measure how quickly bleeding is controlled after device use and watch for any device-related side effects. Blood loss will also be estimated visually from delivery until the device is placed. This monitoring aims to assess the devices feasibility, safety, and effectiveness as a temporary intervention for severe PPH.
CONDITIONS
Temporary Aortic Compression With the Abdominal Tourniquet for Refractory Postpartum Hemorrhage
Y
Yevheniia Poliakova, Ph.D
V
Viktor Oshovskyy, DMSc, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
LLC UkrMedGroup
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 60 minutes
Participants receive standard postpartum hemorrhage management followed by temporary application of the Abdominal Aortic and Junctional Tourniquet - Stabilized device if bleeding remains uncontrolled. The device is applied to the upper abdomen and inflated to temporarily occlude blood flow for up to 60 minutes to control bleeding and allow time for surgical and transfusion interventions.
1 intervention application visit (in-person)
Duration - 6 weeks postpartum
Participants are monitored for safety and device-related adverse events until 6 weeks postpartum after device application.
Approximately 1 follow-up visit
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
D P Riley, R W Burgess
https://pubmed.ncbi.nlm.nih.gov/7818062/Mansoor Khan, J Jeyanathan, J E Smith
https://pubmed.ncbi.nlm.nih.gov/29626141/Mohamed H Soltan, Refaat R Sadek
https://pubmed.ncbi.nlm.nih.gov/21676082/Albaro José Nieto-Calvache, José Miguel Palacios Jaraquemada, Nicolas Basanta...
https://pubmed.ncbi.nlm.nih.gov/35248574/Albaro J Nieto-Calvache, Jose M Palacios-Jaraquemada, Rozi A Aryananda...
https://pubmed.ncbi.nlm.nih.gov/39304012/Mohamed Hashem Soltan, Medhat Farag Faragallah, Mohamed Hany Mosabah...
https://pubmed.ncbi.nlm.nih.gov/19527382/Bijan S Kheirabadi, Michael A Dubick
https://pubmed.ncbi.nlm.nih.gov/30768561/LLC UkrMedGroup
Lead Sponsor